Real-time measurement of free thrombin: Evaluation of the usability of a new thrombin assay for coagulation monitoring during extracorporeal circulation

Thrombosis Research

Volumn 133, Issue 3, 2014, Pages 455-463

  Krajewski, Stefanie ^a   Krauss, Sabrina ^a   Kurz, Julia ^a   Neumann, Bernd ^a   Schlensak, Christian ^a   Wendel, Hans P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

aptamer; coagulation; extracorporeal circulation; heparin; Thrombin

Indexed keywords

HEPARIN; THROMBIN;

BLOOD CLOTTING; BLOOD CLOTTING TEST; DEVICES; DOSE RESPONSE; EXTRACORPOREAL CIRCULATION; HEMOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACORPOREAL CIRCULATION; HEMOSTASIS; HEPARIN; HUMANS; THROMBIN;

EID: 84893912324     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.12.007     Document Type: Article

References (34)

1. V.L. Gott Lillehei, Lewis, and Wangensteen: the right mix for giant achievements in cardiac surgery Ann Thorac Surg 79 2005 S2210 S2213
2. A. Weerasinghe, and K.M. Taylor The platelet in cardiopulmonary bypass Ann Thorac Surg 66 1998 2145 2152
3. S.F. Khuri, J.A. Wolfe, M. Josa, T.C. Axford, I. Szymanski, and S. Assousa et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss J Thorac Cardiovasc Surg 104 1992 94 107
4. D. Paparella, S.J. Brister, and M.R. Buchanan Coagulation disorders of cardiopulmonary bypass: a review Intensive Care Med 30 2004 1873 1881
5. L. Martorell, J. Martinez-Gonzalez, C. Rodriguez, M. Gentile, O. Calvayrac, and L. Badimon Thrombin and protease-activated receptors (PARs) in atherothrombosis Thromb Haemost 99 2008 305 315
6. A.D. Michelson, and M.R. Barnard Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex Blood 70 1987 1673 1678
7. M.J. Rabiet, J.L. Plantier, Y. Rival, Y. Genoux, M.G. Lampugnani, and E. Dejana Thrombin-induced increase in endothelial permeability is associated with changes in cell-to-cell junction organization Arterioscler Thromb Vasc Biol 16 1996 488 496
8. S.R. Coughlin Protease-activated receptors in hemostasis, thrombosis and vascular biology J Thromb Haemost 3 2005 1800 1814
9. G.J. Despotis, G. Gravlee, K. Filos, and J. Levy Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques Anesthesiology 91 1999 1122 1151
10. D. Wardrop, and D. Keeling The story of the discovery of heparin and warfarin Br J Haematol 141 2008 757 763
11. M. Ranucci, A. Ballotta, H. Kandil, G. Isgro, C. Carlucci, and E. Baryshnikova et al. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation Crit Care 15 2011 R275
12. J.H. Levy, and R.M. Sniecinski Activated clotting times, heparin responses, and antithrombin: have we been wrong all these years? Anesth Analg 111 2010 833 835
13. J.C. Fitch, K.L. Geary, G.P. Mirto, D.W. Byrne, and R.L. Hines Heparin management test versus activated coagulation time during cardiovascular surgery: correlation with anti-Xa activity J Cardiothorac Vasc Anesth 13 1999 53 57
14. J.M. Siller-Matula, M. Schwameis, A. Blann, C. Mannhalter, and B. Jilma Thrombin as a multi-functional enzyme. Focus on in vitro and in vivo effects J Thromb Haemost 106 2011 1020 1033
15. J. Muller, T. Becher, J. Braunstein, P. Berdel, S. Gravius, and F. Rohrbach et al. Profiling of active thrombin in human blood by supramolecular complexes Angew Chem Int Ed Engl 50 2011 6075 6078
16. S. Krajewski, J. Kurz, T. Geisler, K. Peter, H.P. Wendel, and A. Straub Combined Blockade of ADP Receptors and PI3-Kinase p110beta Fully Prevents Platelet and Leukocyte Activation during Hypothermic Extracorporeal Circulation PLoS One 7 2012 e38455
17. S. Krajewski, R. Prucek, A. Panacek, M. Avci-Adali, A. Nolte, and A. Straub et al. Hemocompatibility evaluation of different silver nanoparticle concentrations employing a modified Chandler-loop in vitro assay on human blood Acta Biomater 9 2013 7460 7468
18. S. Sinn, T. Scheuermann, S. Deichelbohrer, G. Ziemer, and H.P. Wendel A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4 J Mater Sci Mater Med 22 2011 1521 1528
19. R.M. Sniecinski, and W.L. Chandler Activation of the hemostatic system during cardiopulmonary bypass Anesth Analg 113 2011 1319 1333
20. T.E. Warkentin, A. Greinacher, and A. Koster Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Ann Thorac Surg 87 2009 1633 1640
21. M. Ranucci, A. Ditta, A. Boncilli, M. Cotza, G. Carboni, and S. Brozzi et al. Determinants of antithrombin consumption in cardiac operations requiring cardiopulmonary bypass Perfusion 19 2004 47 52
22. T. Barzu, J.L. van Rijn, M. Petitou, G. Tobelem, and J.P. Caen Heparin degradation in the endothelial cells Thromb Res 47 1987 601 609
23. K.H. Teoh, E. Young, C.A. Bradley, and J. Hirsh Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass Circulation 88 1993 II420 II425
24. G.J. Despotis, A.L. Summerfield, J.H. Joist, L.T. Goodnough, S.A. Santoro, and E. Spitznagel et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations J Thorac Cardiovasc Surg 108 1994 1076 1082
25. P. Hellstern, J. Bach, M. Simon, and W. Saggau Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi J Extra Corpor Technol 39 2007 81 86
26. S. Haselbach, J. Maurer, V. Vogel, S. Harder, C.F. Weber, and D. Baykut et al. A novel method for the direct determination of heparin concentration during cardiopulmonary bypass surgery Clin Chem Lab Med 2013 1 7
27. J.M. Teitel, K.A. Bauer, H.K. Lau, and R.D. Rosenberg Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin-antithrombin complex Blood 59 1982 1086 1097
28. A. Tripodi, and P.M. Mannucci Markers of activated coagulation and their usefulness in the clinical laboratory Clin Chem 42 1996 664 669
29. P.A. Merlini, D. Ardissino, K.A. Bauer, L. Oltrona, A. Pezzano, and B. Bottasso et al. Persistent thrombin generation during heparin therapy in patients with acute coronary syndromes Arterioscler Thromb Vasc Biol 17 1997 1325 1330
30. T.F. Slaughter, T.H. LeBleu, J.M. Douglas Jr., J.B. Leslie, J.K. Parker, and C.S. Greenberg Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers Anesthesiology 80 1994 520 526
31. R. Taneja, P.L. Liaw, S. Al Ghazaly, F. Priestap, J.M. Murkin, and C.M. Martin Effect of cardiopulmonary bypass on thrombin generation and protein C pathway J Cardiothorac Vasc Anesth 27 2013 35 40
32. W.L. Chandler, and T. Velan Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass Blood 101 2003 4355 4362
33. X.F. Sun, Y.S. Chen, Q. Xiao, Y. Wang, J.H. Zhou, and Z.F. Ma et al. Effects of argatroban as an anticoagulant for intermittent veno-venous hemofiltration (IVVH) in patients at high risk of bleeding Nephrol Dial Transplant 26 2011 2954 [U1517]
34. K.M. Song, S. Lee, and C. Ban Aptamers and their biological applications Sensors 12 2012 612 631